Qure Ventures
VC Fund
Herzliya, Israel
Qure Ventures is a VC fund in Herzliya focused on Health Care and Medical Device. Qure Ventures is venture capital firm under OurCrowd. Qure is led by successful digital health veterans with vast experience founding, growing, and exiting companies over the last 20+ years.Qure has established strategic partnerships with key stakeholders in consumer, provider, payer, as well as pharma domains - providing fast track access tomarket and clinical trial opportunities for portfolio companies.Qure is Israel's first exclusively focused digital health fund. The fund focuses predominantly on startups located in Israel, home to world's leading tech + digital health ecosystem. OurCrowd's global network, investment leadership and in-house medical expertise provide Qure with unparalleled deal access and robust diligence.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Qure Ventures invests in
Stages Qure Ventures invests in
Countries Qure Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $8.8M–$20M
- Series B
- $20M–$20M
Investment Focus
Industry
- Health Care 5 (56%)
- Medical Device 3 (33%)
- Medical 2 (22%)
- Hospital 1 (11%)
- Software 1 (11%)
Stage
- Series A 4 (44%)
- Series B 2 (22%)
- Series C 1 (11%)
- Funding Round 1 (11%)
- Convertible Note 1 (11%)
Country
- United States 3 (33%)
- Israel 2 (22%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Allen Kamer
Managing Partner
|
Managing Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CoreMap
|
CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients. | $20M / Series B / Feb 09, 2022 | |
Sweetch
|
Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions. Its hyper-personalized precision engagement platform enables health ecosystem players to build continuous relationships and engage with every individual patient, at scale. | $20M / Series A / Jul 19, 2021 | |
Carevive Systems
|
Carevive Systems provides personalized and dynamic cancer care plans for patients that improve clinical outcomes and enable oncology practices to operate in emerging value-based models. Its care plans continuously update to provide ongoing guidance to patients based on their experiences throughout the journey. Located in North Miami, Florida. | $18M / Series C / Feb 18, 2021 | |
|
CoreMap
|
CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients. | $10.5M / Series A / Sep 16, 2020 | |
CyberMDX
|
CyberMDX is an IOT security leader dedicated to protecting the quality care of health delivery worldwide. CyberMDX provides cloud-based cybersecurity solutions that support the advancement of The Internet of Medical Things. The CyberMDX solution identifies endpoints and assesses vulnerabilities to detect, respond to, and prevent cyber incidents.Deployed worldwide, CyberMDX is designed to integrate with our customers' existing environments through its scalable, easy-to-deploy and agentless solution. | $20M / Series B / Apr 07, 2020 | |
|
Sweetch
|
Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions. Its hyper-personalized precision engagement platform enables health ecosystem players to build continuous relationships and engage with every individual patient, at scale. | $500K / Convertible Note / Jan 31, 2020 | |
|
CyberMDX
|
CyberMDX is an IOT security leader dedicated to protecting the quality care of health delivery worldwide. CyberMDX provides cloud-based cybersecurity solutions that support the advancement of The Internet of Medical Things. The CyberMDX solution identifies endpoints and assesses vulnerabilities to detect, respond to, and prevent cyber incidents.Deployed worldwide, CyberMDX is designed to integrate with our customers' existing environments through its scalable, easy-to-deploy and agentless solution. | $10M / Series A / Jul 17, 2018 | |
BrainQ
|
BrainQ develops a platform for precision neurology therapies to treat the impaired brain using a BCI-based approach. The company was founded in 2016 and is headquartered in Jerusalem, Yerushalayim, Israel. | May 15, 2018 | |
|
BrainQ
|
BrainQ develops a platform for precision neurology therapies to treat the impaired brain using a BCI-based approach. The company was founded in 2016 and is headquartered in Jerusalem, Yerushalayim, Israel. | $8.8M / Series A / May 15, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Qure Ventures invest in?
Qure Ventures invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Series B stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Qure Ventures's check size?
Qure Ventures typically joins rounds of $8.8M–$20M at Series A and $20M–$20M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Qure Ventures participates in.
How do I contact Qure Ventures?
Public channels for Qure Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Qure Ventures?
The team at Qure Ventures includes Allen Kamer (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
